Migraine

Ask a question or start a discussion
NEW TREATMENT ADDED BY A MEMBER
Get enough sleep
Take a nap or go to sleep.
72% of users reported improvements
Procedure
Physical
TRIED
TRYING
How effective is it?
REMOVE ANSWER
completely cured
significant improvement
minor improvement
no difference
worse than before
Helps with prevention
0 (0%)
5 (28%)
8 (44%)
4 (22%)
1 (6%)
ESSENTIAL RESEARCH
Migraine prevalence, disease burden, and the need for preventive therapy.
Compared with previous studies, the epidemiologic profile of migraine has remained stable in the United States during the past 15 years. More than one in four migraineurs are candidates for preventive therapy, and a substantial proportion of those who might benefit from prevention do not receive it.
READ MORE
0REPLY
NEW SYMPTOM ADDED BY A MEMBER
Yes
1
No
0
Light intolerant (Photophobia)
100% reported this symptom
Abnormal intolerance to visual perception of light.
CLINICAL TRIALCompleted
Greater Occipital Nerve Block With Bupivacaine for Acute Migraine
Bronx, United States
All genders
Phase 3
This is a randomized, sham-controlled study of greater occipital nerve block (GONB) using bupivacaine 0.5% for emergency department patients with acute migraine. Patients are only enrolled if they fail first line therapy with metoclopramide.
LEARN MORE
0REPLY1 YEAR AGO
ESSENTIAL RESEARCH
Prevalence and burden of migraine in the United States: data from the American Migraine Study II.
Two methodologically identical national surveys in the United States conducted 10 years apart show that the prevalence and distribution of migraine have remained stable over the last decade. Migraine-associated disability remains substantial and pervasive. The number of migraineurs has increased from 23.6 million in 1989 to 27.9 million in 1999 commensurate with the growth of the population. Migraine is an important target for public health interventions because it is highly prevalent and disabling.
...see more
READ MORE
0REPLY
ESSENTIAL RESEARCH
Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine.
The CGRP antagonist BIBN 4096 BS was effective in treating acute attacks of migraine.
READ MORE
0REPLY
Get important Migraine updates delivered to your email.
NEW TREATMENT ADDED BY A MEMBER
100 Studies
Sumatriptan (imigran, sumatriptan succinate)
Prescription medication for the treatment of migraines.
53% of users reported improvements
Prescription
TRIED
TRYING
How effective is it?
REMOVE ANSWER
completely cured
significant improvement
minor improvement
no difference
worse than before
Helps with prevention
0 (0%)
4 (24%)
5 (29%)
4 (24%)
4 (24%)
NEW SYMPTOM ADDED BY A MEMBER
Yes
1
No
0
Headache
100% reported this symptom
Headache is the symptom of pain anywhere in the region of the head or neck.
ESSENTIAL RESEARCH
American Medical Society for Sports Medicine position statement: concussion in sport.
▸ Primary prevention of some injuries may be possible with modification and enforcement of the rules and fair play. ▸ Helmets, both hard (football, lacrosse and hockey) and soft (soccer, rugby) are best suited to prevent impact injuries (fracture, bleeding, laceration, etc.) but have not been shown to reduce the incidence and severity of concussions. ▸ There is no current evidence that mouth guards can reduce the severity of or prevent concussions. ▸ Secondary prevention may be possible by appropriate RTP management.
...see more
READ MORE
0REPLY
CLINICAL TRIALCompleted
Acupuncture as Migraine Prophylaxis in Reducing Frequency, Duration and Intensity of Migraine With Minimum Acupoint, Seen up to Eight Weeks From Baseline
Jakarta Pusat, Indonesia
All genders
Migraine is a primary headache attack, specific, paroxysmal, with or without aura, with subjective manifestations both before and after the attack, a chronic type of headache with symptoms of recurrence, attacks at productive age and can cause a decrease in work productivity up to 80%, so that it will affect the quality of life, economic life and education globally which leads to losses for migraine sufferers and institutions where migraine sufferers attend school, work and in the lives of sufferers' families.
...see more
LEARN MORE
0REPLY1 YEAR AGO
NEW TREATMENT ADDED BY A MEMBER
Drink caffeine
Have drinks or food that contain caffeine. Coffee is the most common one that comes to my mind.
56% of users reported improvements
Home Remedy
Lifestyle
TRIED
TRYING
How effective is it?
REMOVE ANSWER
completely cured
significant improvement
minor improvement
no difference
worse than before
Helps with prevention
0 (0%)
1 (6%)
8 (50%)
5 (31%)
2 (13%)
ESSENTIAL RESEARCH
Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors.
A projection to the US population suggests that 8.7 million females and 2.6 million males suffer from migraine headache with moderate to severe disability. Of these, 3.4 million females and 1.1 million males experience one or more attacks per month. Females between ages 30 to 49 years from lower-income households are at especially high risk of having migraines and are more likely than other groups to use emergency care services for their acute condition.
...see more
READ MORE
0REPLY
ESSENTIAL RESEARCH
Risk factors for progression of visual field abnormalities in normal-tension glaucoma.
Whereas risk factors for prevalence help select populations within which to screen for glaucoma, the factors that affect the rate of progression help decide the expected prognosis of the individual's untreated disease and thereby the frequency of follow-up and aggressiveness of the therapy to be undertaken.
...see more
READ MORE
0REPLY
ESSENTIAL RESEARCH
Migraine and cardiovascular disease: systematic review and meta-analysis.
Migraine is associated with a twofold increased risk of ischaemic stroke, which is only apparent among people who have migraine with aura. Our results also suggest a higher risk among women and risk was further magnified for people with migraine who were aged less than 45, smokers, and women who used oral contraceptives. We did not find an overall association between any migraine and myocardial infarction or death due to cardiovascular disease. Too few studies are available to reliably evaluate the impact of modifying factors, such as migraine aura, on these associations.
...see more
READ MORE
0REPLY
CLINICAL TRIALRecruiting
A Study to Test if Fremanezumab is Effective in Preventing Episodic Migraine in Patients 6 to 17 Years of Age
4 Locations
All genders
Phase 3
The primary objective of the study is to evaluate the effectiveness of fremanezumab as compared to placebo for the preventive treatment of episodic migraine (EM). Secondary objectives are to further demonstrate the efficacy of Fremanezumab as compared to placebo for the preventive treatment of EM, to evaluate the safety and tolerability of Fremanezumab in the preventive treatment of EM and to evaluate the immunogenicity of Fremanezumab and the impact of antidrug antibodies (ADAs) on clinical outcomes in participants exposed to Fremanezumab. The total duration of the study is planned to be up to 36 months.
...see more
LEARN MORE
0REPLY1 YEAR AGO
ESSENTIAL RESEARCH
Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine.
Dysfunction of the neuronal sodium channel SCN1A can cause familial hemiplegic migraine. Our findings have implications for the understanding of migraine aura. Moreover, our study reinforces the molecular links between migraine and epilepsy, two common paroxysmal disorders.
READ MORE
0REPLY
ABOUT
A migraine is a primary headache disorder characterized by recurrent headaches that are moderate to severe. Typically, the headaches affect one half of the head, are pulsating in nature, and last from two to 72 hours. Associated symptoms may include nausea, vomiting, and sensitivity to light, sound, or smell. The pain is generally made worse by physical activity. Up to one-third of people have an aura: typically a short period of visual disturbance which signals that the headache will soon occur. Occasionally, an aura can occur with little or no headache following it.Wikipedia
SHOW MORE
Get the latest Migraine research, treatments, and clinical trials in your email.